rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Dishman Pharmaceuticals & Chemicals Ltd. - Research Center
532526 DISHMAN Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Income
Operating income 510.39 478.69 473.28 484.64 463.40
Expenses
Material consumed 194.38 199.90 176.07 179.57 195.63
Manufacturing expenses 29.74 31.67 29.47 32.99 25.02
Personnel expenses 65.89 58.88 58.38 58.21 45.22
Selling expenses - - - - -
Adminstrative expenses 49.60 39.15 33.15 46.32 52.57
Expenses capitalised - - - - -
Cost of sales 339.61 329.60 297.07 317.09 318.45
Operating profit 170.78 149.09 176.21 167.55 144.96
Other recurring income 62.38 67.00 55.98 13.59 11.77
Adjusted PBDIT 233.16 216.09 232.19 181.14 156.73
Financial expenses 68.66 68.13 69.22 51.10 57.54
Depreciation 44.25 44.13 44.13 35.34 31.66
Other write offs - - - - -
Adjusted PBT 120.25 103.83 118.84 94.70 67.52
Tax charges 33.10 45.35 32.05 31.52 22.68
Adjusted PAT 87.15 58.48 86.79 63.18 44.84
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 87.15 58.48 86.79 63.18 44.84
Earnigs before appropriation 228.63 175.90 144.86 83.58 69.16
Equity dividend 19.43 12.85 8.04 8.11 8.11
Preference dividend - - - - -
Dividend tax -3.29 3.29 1.65 1.57 1.57
Retained earnings 212.49 159.76 135.18 73.90 59.48
Close
Add Dishman Pharmaceuticals & Chemicals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Dishman Pharmaceuticals & Chemicals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close